Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Bayer Partner on Cancer Companion Dx

NEW YORK (GenomeWeb News) – Qiagen today said that it will collaborate with Bayer HealthCare on developing companion diagnostics for Bayer drugs with an initial focus on those that target solid tumors.

The companion diagnostic tests will run on Qiagen's QIA symphony automated instruments. In addition, the partners said that they will collaborate on developing technologies for patient profiling, which may result on research-use-only products for exploratory and translational medicine, said Qiagen.

"The first collaborations for Bayer HealthCare and Qiagen include companion diagnostics based on the identification of patients who may respond to therapies in clinically unmet disease classifications," Helge Lubenow, SVP of the molecular diagnostics business area and member of the executive committee of Qiagen, said in a statement. "Our agreement also lays the groundwork for a strong partnership in creating future companion diagnostics both inside and outside of oncology."

Financial and other terms of the alliance were not disclosed.

Qiagen said that it has more than 15 companion diagnostic collaborations ongoing with pharmaceutical and biotech companies.

In early July the US Food and Drug Administration cleared for marketing Qiagen's therascreen KRAS RGQ PCR Kit to be sold as a companion diagnostic test for Erbitux (cetuximab), a drug used for treating colorectal cancer.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.